Evidence mapPaperPMID 27616627Full record

ArticleScientific reports2016

Sustained elevation of NF-κB activity sensitizes offspring of maternal inflammation to hypertension via impairing PGC-1α recovery.

Yafei Deng, Qi Zhang, Hongqin Luo, Xianhua Chen, Qi Han, Fangjie Wang, Pei Huang, Wenjing Lai, Xiao Guan, Xiaodong Pan and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 3 countries.

Yafei DengInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Qi ZhangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Hongqin LuoInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Xianhua ChenDiagosis and Treatment Center for Servicemen, Southwest Hospital, Third Military Medical University, Chongqing, China.
Qi HanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Fangjie WangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Pei HuangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Wenjing LaiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Xiao GuanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Xiaodong PanInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Yan JiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Wei GuoInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Ling CheInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Yuan TangInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Liangqi GuThe Center for Disease Control and Prevention of Chengdu Military Command, Chengdu, China.
Jianhua YuDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
Michael NamakaColleges of Pharmacy and Medicine, University of Manitoba, Winnipeg, MB, Canada.
Youcai DengInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Xiaohui LiInstitute of Materia Medica, College of Pharmacy, Third Military Medical University, Chongqing, China.
Army Medical University · CNLiaocheng Center for Disease Control and PreventionSouthwest Hospital · CNThe Ohio State University · USUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence has demonstrated that maternal detrimental factors, including inflammation, contribute to the development of hypertension in the offspring. The current study found that offspring subjected to prenatal exposure of inflammation by lipopolysaccharide (LPS) challenge during the second semester showed significantly increased systolic blood pressure. In addition, these offspring also displayed augmented vascular damage and reactive oxygen species (ROS) levels in thoracic aortas when challenged with deoxycorticosterone acetate and high-salt diet (DOCA-salt). Interestingly, the antioxidant N-acetyl-L-cysteine markedly reversed these changes. Mechanistically, prenatal LPS exposure led to pre-existing elevated peroxisome proliferators-activated receptor-γ co-activator (PGC)-1α, a critical master of ROS metabolism, which up-regulated the ROS defense capacity and maintained the balance of ROS generation and elimination under resting state. However, continued elevation of NF-κB activity significantly suppressed the rapid recovery of PGC-1α expression response to DOCA-salt challenge in offspring that underwent prenatal inflammatory stimulation. This was further confirmed by using a NF-κB inhibitor (N-p-Tosyl-L-phenylalanine chloromethyl ketone) that restored PGC-1α recovery and prevented blood pressure elevation induced by DOCA-salt. Our results suggest that maternal inflammation programmed proneness to NF-κB over-activation which impaired PGC-1α-mediated anti-oxidant capacity resulting in the increased sensitivity of offspring to hypertensive damage.

Indexed as

AnimalsAntioxidantsAorta, ThoracicBlood PressureDesoxycorticosteroneDisease Models, AnimalFemaleGene Expression RegulationHumansHypertensionInflammationLipopolysaccharidesMaternal ExposureNF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaRatsAntioxidantsDesoxycorticosteroneLipopolysaccharidesNF-kappa BPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, ratReactive Oxygen Species

Identifiers

PMID27616627
PMCPMC5018852
OpenAlexW2518859174

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.